Colorimetric assay system for screening antiviral compounds against hepatitis B virus

Microbiology and Immunology

Volumn 40, Issue 2, 1996, Pages 153-159

  Sudo, Kenji ^a,b   Konno, Kenji ^a   Shigeta, Shiro ^b   Yokota, Tomoyuki ^a  

^a Rational Drug Design Laboratories   (Japan)

^b FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

HB611 cells; Hepatitis B virus; Hybrid capture detection; PCR

Indexed keywords

9 (3 HYDROXY 2 PHOSPHONOMETHOXYPROPYL)ADENINE; ACICLOVIR; ADENINE DERIVATIVE; ANTIVIRUS AGENT; CIDOFOVIR; GUANINE DERIVATIVE; LAMIVUDINE; PURINE DERIVATIVE; VIDARABINE;

ANTIVIRAL ACTIVITY; ARTICLE; COLORIMETRY; DRUG DETERMINATION; DRUG SCREENING; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL;

HEPATITIS B VIRUS;

EID: 0030029381     PISSN: 03855600     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1348-0421.1996.tb03319.x     Document Type: Article

References (18)

1. Alard, P., Lantz, O., Sebagh, M., Calvo, C.F., Weill, D., Chavanel, G., Senik, A., and Charpentier, B. 1993. A versatile ELISA-PCR assay for mRNA quantitation from a few cells. BioTecniques 15: 730-737.
2. Condreay, L.D., Jansen, R.W., Powdrill, T.F., Johnson, L.C., Selleseth, D.W., Paff, M.T., Daluge, S.M., Painter, G.R., Furman, P.A., Ellis, M.N., and Averett, D.R. 1994. Evaluation of the potent anti-hepatitis B virus against (-)cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine in a novel in vivo model. Antimicrob. Agents Chemother. 38: 616-619.
3. Furman, P.A., Davis, M., Liotta, D.C., Paff, M., Frick, L.W., Nelson, D.J., Dornsife, R.E., Wurster, J.A., Wilson, L.J., Fyfe, J.A., Tuttle, J.V., Miller, W.H., Condreay, L., Averett, D.R., Schinazi, R.F., and Painter, G.R. 1992. The antihepatitis B virus activities, cytotoxicities, and anabolic profiles of the (-) and (+) enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine. Antimicrob. Agents Chemother. 36: 2686-2692.
4. Heijtink, R.A., De Wilde, G.A., Kruining, J., Berk, L., Balzarini, J., De Clercq, E., Holy, A., and Schalm, S.W. 1993. Inhibitory effect of 9-(2-phosphonylmethoxyethyl)-adenine (PMEA) on human and duck hepatitis B virus infection. Antiviral Res. 21: 141-153.
5. Jansen, R.W., Johnson, L.C., and Averett, D.R. 1993. High-capacity in vitro assessment of anti-hepatitis B virus compound selectivity by a virion-specific polymerase chain reaction assay. Antimicrob. Agents Chemother. 37: 441-447.
6. Lehtovaara, P., Uusi-Oukari, M., Buchert, P., Laaksonen, M., Bengtstrom, M., and Ranki, M. 1993. Quantitative PCR for hepatitis B virus with colorimetric detection. PCR Methods Applic. 3: 169-175.
7. Nagahata, T., Araki, K., Yamamura, I., and Matsubara, K. 1992. Inhibition of intrahepatic hepatitis B virus replication by antiviral drugs in a novel transgenic mouse model. Antimicrob. Agent Chemother. 36: 2042-2045.
8. Nagahata, T., Kitagawa, M., and Matsubara, K. 1994. Effect of oxetanocin G, a novel nucleoside analog, on DNA synthesis by hepatitis B virus virion. Antimicrob. Agents Chemother. 38: 707-712.
9. Nozaki, C., Miyanohara, A., Fujiyama, A., Hamada, F., Ohtomo, N., and Matsubara, K. 1985. Two mammalian cell systems for propagation of the hepatitis B virus genome in extrachromosomal and chromosomally integrated states: production of the surface and e antigens. Gene 38: 39-44.
10. Sabbatini, A.R.M., Werner, P.A., Guha, C., Paddock, G.V., and Galbraith, R.M. 1993. The vitamin D-binding protein gene: quantitation of amplified nucleic acids by ELISA. BioTecniques 15: 706-713.
11. Sells, M.A., Chen, M.-F., and Acs, G. 1987. Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA. Proc. Natl. Acad. Sci. U.S.A. 84: 1005-1009.
12. Sherker, A.H., Hirota, K., Omata, M., and Okuda, K. 1986. Foscarnet decreases serum and liver duck hepatitis B virus DNA in chronically infected ducks. Gastroenterology 91: 818-824.
13. Tsurimoto, T., Fujiyama, A., and Matsubara, M. 1987. Stable expression and replication of hepatitis B virus genome in an integrated state in a human hepatoma cell line transfected with the cloned viral DNA. Proc. Natl. Acad. Sci. U.S.A. 84: 444-448.
14. Ueda, K., Tsurimoto, T, Nagahata, T., Chisaka, O., and Matsubara, K. 1989. An in vitro system for screening anti-hepatitis B virus drugs. Virology 169: 213-216.
15. Van Draanen, N.A., Tisdale, M., Parry, N.R., Jansen, R., Dornsife, R.E., Tuttle, J.V., Averett, D.R., and Koszalka, G.W. 1994. Influence of stereochemistry on antiviral activities and resistance profiles of dideoxycytidine nucleosides. Antimicrob. Agents Chemother. 38: 868-871.
16. Yokota, T., Konno, K., Chonan, E., Mochizuki, S., Kojima, K., Shigeta, S., and De Clercq, E. 1990. Comparative activities of several nucleoside analogs against duck hepatitis B virus in vitro. Antimicrob. Agents Chemother. 34: 1326-1330.
17. Yokota, T., Mochizuki, S., Konno, K., Mori, S., Shigeta, S., and De Clercq, E. 1991. Inhibitory effects of selected compounds on human hepatitis B virus DNA synthesis. Antimicrob. Agents Chemother. 35: 394-397.
18. Yokota, T., Konno, K., Shigeta, S., Holy, A., Balzarini, J., and De Clercq, E. 1994. Inhibitory effects of acyclic nucleoside phosphate analogues on hepatitis B virus DNA synthesis in HB611 cells. Antiviral Chem. Chemother. 5: 57-63.